Association between polymorphism rs2032487 in the non-muscle myosin heavy chain IIA gene (MHY9) and chronic kidney disease secondary to type 2 diabetes mellitus in a population of the Canary Islands

Sociedad Española de Nefrología. Registros de Enfermos Renales. Available from: http://www.senefro.org/modules.php?name=webstructure&idwebstructure=29 [accessed 17.08.18]. Lorenzo, 2010, Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk, Nephrol Dial Transplant, 25, 2283, 10.1093/ndt/gfp761 Lorenzo, 2010, End stage renal disease associated with diabetes in the Canary Islands: a public health problem with significant human suffering and high economic costs, Nefrología, 30, 381 Flores, 2003, A predominant European ancestry of paternal lineages from Canary Islands, Ann Hum Genet, 67, 138, 10.1046/j.1469-1809.2003.00015.x Arnaiz-Villena, 2015, Origin of Ancient Canary Islanders (Guanches): presence of Atlantic/Iberian HLA and Y chromosome genes and ancient Iberian language, Int J Mod Anthrop, 8, 67, 10.4314/ijma.v1i8.4 Maca-Meyer, 2004, A tale of aborigines, conquerors and slaves: Alu insertion polymorphisms and the peopling of Canary Islands, Ann Hum Genet, 68, 600, 10.1046/j.1529-8817.2003.00125.x Martinez-Laso, 2018, North African-Mediterranean HLA genetic contribution in a population of the kidney transplant waiting list patients of Canary origin (Gran Canaria), HLA, 92, 12, 10.1111/tan.13298 Barsoum, 2013, Burden of chronic kidney disease: North Africa, Kidney Int Suppl (2011), 3, 164, 10.1038/kisup.2013.5 Stanifer, 2014, The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis, Lancet Glob Health, 2, e174, 10.1016/S2214-109X(14)70002-6 Kao, 2008, MYH9 is associated with nondiabetic end-stage renal disease in African Americans, Nat Genet, 40, 1185, 10.1038/ng.232 Kopp, 2008, MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis, Nat Genet, 40, 1175, 10.1038/ng.226 Genovese, 2010, Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science, 329, 841, 10.1126/science.1193032 Tzur, 2010, Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene, Hum Genet, 128, 345, 10.1007/s00439-010-0861-0 Boronat, 2014, Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus, Ren Fail, 36, 166, 10.3109/0886022X.2013.835266 R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing. Available from: https://www.Rproject.org/ [accessed 17.08.18]. Tayo, 2013, Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians, Int Urol Nephrol, 45, 485, 10.1007/s11255-012-0263-4 O'Seaghdha, 2011, The MYH9/APOL1 region and chronic kidney disease in European-Americans, Hum Mol Genet, 20, 2450, 10.1093/hmg/ddr118 Freedman, 2009, Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD, Nephrol Dial Transplant, 24, 3366, 10.1093/ndt/gfp316 McDonough, 2011, A genome-wide association study for diabetic nephropathy genes in African Americans, Kidney Int, 79, 563, 10.1038/ki.2010.467 Iyengar, 2015, Genome-wide association and trans-ethnic meta-analysis for advanced diabetic kidney disease: Family Investigation of Nephropathy and Diabetes (FIND), PLoS Genet, 11, e1005352, 10.1371/journal.pgen.1005352 Palmer, 2014, Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease, PLOS ONE, 9, e88273, 10.1371/journal.pone.0088273 Cooke, 2012, Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans, Nephrol Dial Transplant, 27, 1505, 10.1093/ndt/gfr522 McKnight, 2012, Association of MYH9/APOL1 with chronic kidney disease in a UK population, Nephrol Dial Transplant, 27, 3660, 10.1093/ndt/gfs181 Kopp, 2010, MYH9 Genetic variants associated with glomerular disease: what is the role for genetic testing?, Semin Nephrol, 30, 409, 10.1016/j.semnephrol.2010.06.007 Tavira, 2013, Association between a MYH9 polymorphism (rs3752462) and renal function in the Spanish RENASTUR cohort, Gene, 520, 73, 10.1016/j.gene.2013.02.024 Ensembl.org. Human (GRCh38.p12). Available from: http://www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=22:36298701-36299701;v=rs4821480;vdb=variation;vf=3070653#population_freq_AFR [accessed 17.08.18]. Oleksyk, 2010, Worldwide distribution of the MYH9 kidney disease susceptibility alleles and haplotypes: evidence of historical selection in Africa, PLoS ONE, 5, e11474, 10.1371/journal.pone.0011474 Wijsman, 2012, The role of large pedigrees in an era of high-throughput sequencing, Hum Genet, 131, 1555, 10.1007/s00439-012-1190-2 Johnstone, 2011, Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy, Mol Cell Biol, 31, 2162, 10.1128/MCB.05234-11 Zhang, 2012, Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A, Blood, 119, 238, 10.1182/blood-2011-06-358853 Cechova, 2018, MYH9 E1841K mutation augments proteinuria and podocyte injury and migration, J Am Soc Nephrol, 29, 155, 10.1681/ASN.2015060707 Cignarelli, 2008, Cigarette smoking and kidney dysfunction in diabetes mellitus, J Nephrol, 21, 180 Nakamura, 2003, Effect of cigarette smoking on urinary podocyte excretion in early diabetic nephropathy, Diabetes Care, 26, 1324, 10.2337/diacare.26.4.1324